ge healthcare uk limited
ge healthcare uk limited Company Information
Company Number
03337033
Website
www.gehealthcare.comRegistered Address
pollards wood nightingales lane, chalfont st. giles, buckinghamshire, HP8 4SP
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Telephone
01494544000
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
ge medical systems ltd 100%
ge healthcare uk limited Estimated Valuation
Pomanda estimates the enterprise value of GE HEALTHCARE UK LIMITED at £15.7m based on a Turnover of £16.5m and 0.96x industry multiple (adjusted for size and gross margin).
ge healthcare uk limited Estimated Valuation
Pomanda estimates the enterprise value of GE HEALTHCARE UK LIMITED at £2.7m based on an EBITDA of £745k and a 3.63x industry multiple (adjusted for size and gross margin).
ge healthcare uk limited Estimated Valuation
Pomanda estimates the enterprise value of GE HEALTHCARE UK LIMITED at £26.9m based on Net Assets of £15.7m and 1.71x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ge Healthcare Uk Limited Overview
Ge Healthcare Uk Limited is a live company located in buckinghamshire, HP8 4SP with a Companies House number of 03337033. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in March 1997, it's largest shareholder is ge medical systems ltd with a 100% stake. Ge Healthcare Uk Limited is a mature, mid sized company, Pomanda has estimated its turnover at £16.5m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ge Healthcare Uk Limited Health Check
Pomanda's financial health check has awarded Ge Healthcare Uk Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
5 Weak
Size
annual sales of £16.5m, make it in line with the average company (£18.1m)
£16.5m - Ge Healthcare Uk Limited
£18.1m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Ge Healthcare Uk Limited
- - Industry AVG
Production
with a gross margin of 3.9%, this company has a higher cost of product (36.1%)
3.9% - Ge Healthcare Uk Limited
36.1% - Industry AVG
Profitability
an operating margin of 2.7% make it less profitable than the average company (5.1%)
2.7% - Ge Healthcare Uk Limited
5.1% - Industry AVG
Employees
with 22 employees, this is below the industry average (106)
22 - Ge Healthcare Uk Limited
106 - Industry AVG
Pay Structure
on an average salary of £524.9k, the company has a higher pay structure (£42k)
£524.9k - Ge Healthcare Uk Limited
£42k - Industry AVG
Efficiency
resulting in sales per employee of £748.5k, this is more efficient (£178.6k)
£748.5k - Ge Healthcare Uk Limited
£178.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Ge Healthcare Uk Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (48 days)
0 days - Ge Healthcare Uk Limited
48 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Ge Healthcare Uk Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Ge Healthcare Uk Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 44.8%, this is a lower level of debt than the average (69.9%)
44.8% - Ge Healthcare Uk Limited
69.9% - Industry AVG
GE HEALTHCARE UK LIMITED financials
Ge Healthcare Uk Limited's latest turnover from December 2022 is £16.5 million and the company has net assets of £15.7 million. According to their latest financial statements, Ge Healthcare Uk Limited has 22 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 16,466,000 | 14,693,000 | 7,246,000 | 0 | 141,750,000 | 159,921,000 | 105,450,000 | 111,150,000 | 84,701,000 | 71,251,000 | 62,744,000 | 60,720,000 | 124,011,000 | 112,492,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 15,818,000 | 13,685,000 | 6,655,000 | 0 | 107,679,000 | 128,843,000 | 72,560,000 | 78,199,000 | 58,995,000 | 43,885,000 | 36,450,000 | 39,067,000 | 82,518,000 | 69,104,000 |
| Gross Profit | 648,000 | 1,008,000 | 591,000 | 0 | 34,071,000 | 31,078,000 | 32,890,000 | 32,951,000 | 25,706,000 | 27,366,000 | 26,294,000 | 21,653,000 | 41,493,000 | 43,388,000 |
| Admin Expenses | 209,000 | 57,000 | 0 | -511,000 | 25,823,000 | 27,422,000 | 38,229,000 | 17,354,000 | 23,456,000 | 19,210,000 | 42,847,000 | 69,369,000 | 40,363,000 | 39,794,000 |
| Operating Profit | 439,000 | 951,000 | 591,000 | 511,000 | 8,248,000 | 3,656,000 | -5,339,000 | 15,597,000 | 2,250,000 | 8,156,000 | -16,553,000 | -47,716,000 | 1,130,000 | 3,594,000 |
| Interest Payable | 46,000 | 0 | 1,314,000 | 1,465,000 | 4,567,000 | 4,776,000 | 29,925,000 | 18,927,000 | 17,257,000 | 16,820,000 | 2,860,000 | 866,000 | 2,171,000 | 2,294,000 |
| Interest Receivable | 13,000 | 20,000 | 416,000 | 364,000 | 1,903,000 | 920,000 | 0 | 0 | 0 | 0 | 0 | 0 | 74,000 | 181,000 |
| Pre-Tax Profit | 2,501,000 | 971,000 | 797,268,000 | 51,936,000 | 5,584,000 | -200,000 | -35,105,000 | -203,330,000 | -15,007,000 | -8,664,000 | -19,413,000 | -48,582,000 | -967,000 | 10,794,000 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,245,000 | 203,000 | 2,971,000 | -937,000 |
| Profit After Tax | 2,501,000 | 971,000 | 797,268,000 | 51,936,000 | 5,584,000 | -200,000 | -35,105,000 | -203,330,000 | -15,007,000 | -8,664,000 | -21,658,000 | -48,379,000 | 2,004,000 | 9,857,000 |
| Dividends Paid | 0 | 0 | 0 | 330,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 2,501,000 | 971,000 | 797,268,000 | -278,064,000 | 5,584,000 | -200,000 | -35,105,000 | -203,330,000 | -15,007,000 | -8,664,000 | -21,658,000 | -48,379,000 | 2,004,000 | 9,857,000 |
| Employee Costs | 11,548,000 | 11,316,000 | 17,705,000 | 34,419,000 | 24,556,000 | 22,970,000 | 23,099,000 | 24,783,000 | 22,658,000 | 20,870,000 | 21,250,000 | 18,463,000 | 16,067,000 | 14,180,000 |
| Number Of Employees | 22 | 21 | 93 | 304 | 285 | 270 | 271 | 264 | 242 | 242 | 244 | 232 | 216 | 173 |
| EBITDA* | 745,000 | 1,291,000 | 1,010,000 | 1,730,000 | 11,972,000 | 7,596,000 | -1,777,000 | 20,072,000 | 6,454,000 | 10,878,000 | -14,048,000 | -46,301,000 | 1,988,000 | 3,968,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 5,911,000 | 5,470,000 | 5,811,000 | 5,021,000 | 16,762,000 | 11,925,000 | 5,823,000 | 6,175,000 | 6,377,000 | 19,552,000 | 15,619,000 | 12,564,000 | 12,133,000 | 8,371,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 9,483,000 | 7,402,000 | 5,768,000 | 8,962,000 | 13,149,000 | 167,000 | 217,000 | 0 | 371,000 | 743,000 |
| Investments & Other | 756,000 | 81,158,000 | 81,158,000 | 81,158,000 | 347,368,000 | 330,567,000 | 311,716,000 | 1,312,947,000 | 1,510,639,000 | 1,510,639,000 | 1,510,639,000 | 1,625,405,000 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 22,015,000 | 31,356,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 6,667,000 | 86,628,000 | 86,969,000 | 86,179,000 | 395,628,000 | 381,250,000 | 323,307,000 | 1,328,084,000 | 1,530,165,000 | 1,530,358,000 | 1,526,475,000 | 1,637,969,000 | 12,504,000 | 9,114,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 3,178,000 | 2,181,000 | 2,296,000 | 1,772,000 | 2,439,000 | 2,394,000 | 2,549,000 | 2,540,000 | 2,870,000 | 2,422,000 |
| Trade Debtors | 0 | 0 | 2,000 | 0 | 316,000 | 1,931,000 | 888,000 | 11,203,000 | 4,121,000 | 1,973,000 | 3,919,000 | 3,610,000 | 964,000 | 1,800,000 |
| Group Debtors | 21,852,000 | 27,243,000 | 25,086,000 | 49,317,000 | 325,142,000 | 362,403,000 | 403,408,000 | 5,706,000 | 6,754,000 | 14,953,000 | 30,171,000 | 15,342,000 | 14,513,000 | 49,361,000 |
| Misc Debtors | 0 | 473,000 | 489,000 | 554,000 | 1,830,000 | 245,000 | 943,000 | 1,328,000 | 1,401,000 | 1,488,000 | 1,483,000 | 2,969,000 | 3,128,000 | 2,018,000 |
| Cash | 0 | 0 | 0 | 15,000 | 303,000 | 162,000 | 189,000 | 21,000 | 0 | 95,000 | 0 | 300,000 | 376,000 | 93,000 |
| misc current assets | 0 | 0 | 0 | 83,624,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 21,852,000 | 27,716,000 | 25,577,000 | 133,510,000 | 330,769,000 | 366,922,000 | 407,724,000 | 20,030,000 | 14,715,000 | 20,903,000 | 38,122,000 | 24,761,000 | 21,851,000 | 55,694,000 |
| total assets | 28,519,000 | 114,344,000 | 112,546,000 | 219,689,000 | 726,397,000 | 748,172,000 | 731,031,000 | 1,348,114,000 | 1,544,880,000 | 1,551,261,000 | 1,564,597,000 | 1,662,730,000 | 34,355,000 | 64,808,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 916,000 | 0 | 235,000 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 14,000 | 4,000 | 150,000 | 0 | 3,580,000 | 11,524,000 | 2,323,000 | 1,365,000 | 1,069,000 | 1,143,000 | 669,000 | 1,260,000 | 924,000 | 318,000 |
| Group/Directors Accounts | 11,089,000 | 1,291,000 | 5,000 | 32,852,000 | 280,000,000 | 291,693,000 | 292,880,000 | 875,614,000 | 869,160,000 | 72,331,000 | 74,502,000 | 48,842,000 | 43,170,000 | 74,077,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 530,000 | 49,000 | 42,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 2,000 | 0 | 0 | 697,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 1,667,000 | 3,896,000 | 5,664,000 | 36,866,000 | 15,955,000 | 13,286,000 | 12,503,000 | 13,505,000 | 12,111,000 | 12,578,000 | 15,207,000 | 12,898,000 | 10,766,000 | 12,967,000 |
| total current liabilities | 12,772,000 | 5,191,000 | 5,819,000 | 70,415,000 | 299,535,000 | 317,033,000 | 307,755,000 | 890,526,000 | 883,256,000 | 86,052,000 | 90,613,000 | 63,000,000 | 54,860,000 | 87,362,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 788,655,000 | 788,668,000 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 140,000 | 361,000 | 338,000 | 84,000 | 799,000 | 1,150,000 | 167,000 | 103,000 | 121,000 | 247,000 | 162,000 | 186,000 | 309,000 |
| total long term liabilities | 0 | 140,000 | 361,000 | 338,000 | 84,000 | 799,000 | 1,150,000 | 167,000 | 103,000 | 788,776,000 | 788,915,000 | 162,000 | 186,000 | 309,000 |
| total liabilities | 12,772,000 | 5,331,000 | 6,180,000 | 70,753,000 | 299,619,000 | 317,832,000 | 308,905,000 | 890,693,000 | 883,359,000 | 874,828,000 | 879,528,000 | 63,162,000 | 55,046,000 | 87,671,000 |
| net assets | 15,747,000 | 109,013,000 | 106,366,000 | 148,936,000 | 426,778,000 | 430,340,000 | 422,126,000 | 457,421,000 | 661,521,000 | 676,433,000 | 685,069,000 | 1,599,568,000 | -20,691,000 | -22,863,000 |
| total shareholders funds | 15,747,000 | 109,013,000 | 106,366,000 | 148,936,000 | 426,778,000 | 430,340,000 | 422,126,000 | 457,421,000 | 661,521,000 | 676,433,000 | 685,069,000 | 1,599,568,000 | -20,691,000 | -22,863,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 439,000 | 951,000 | 591,000 | 511,000 | 8,248,000 | 3,656,000 | -5,339,000 | 15,597,000 | 2,250,000 | 8,156,000 | -16,553,000 | -47,716,000 | 1,130,000 | 3,594,000 |
| Depreciation | 306,000 | 340,000 | 419,000 | 718,000 | 703,000 | 376,000 | 353,000 | 200,000 | 4,157,000 | 2,672,000 | 2,489,000 | 1,044,000 | 486,000 | 2,000 |
| Amortisation | 0 | 0 | 0 | 501,000 | 3,021,000 | 3,564,000 | 3,209,000 | 4,275,000 | 47,000 | 50,000 | 16,000 | 371,000 | 372,000 | 372,000 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,245,000 | 203,000 | 2,971,000 | -937,000 |
| Stock | 0 | 0 | 0 | -3,178,000 | 997,000 | -115,000 | 524,000 | -667,000 | 45,000 | -155,000 | 9,000 | -330,000 | 448,000 | 2,422,000 |
| Debtors | -5,864,000 | 2,139,000 | -24,294,000 | -299,432,000 | -46,632,000 | -9,304,000 | 387,002,000 | 5,961,000 | -6,138,000 | -17,159,000 | 13,652,000 | 3,316,000 | -34,574,000 | 53,179,000 |
| Creditors | 10,000 | -146,000 | 150,000 | -3,580,000 | -7,944,000 | 9,201,000 | 958,000 | 296,000 | -74,000 | 474,000 | -591,000 | 336,000 | 606,000 | 318,000 |
| Accruals and Deferred Income | -2,229,000 | -1,768,000 | -31,202,000 | 20,911,000 | 2,669,000 | 783,000 | -1,002,000 | 1,394,000 | -467,000 | -2,629,000 | 2,309,000 | 2,132,000 | -2,201,000 | 12,967,000 |
| Deferred Taxes & Provisions | -140,000 | -221,000 | 23,000 | 254,000 | -715,000 | -351,000 | 983,000 | 64,000 | -18,000 | -126,000 | 85,000 | -24,000 | -123,000 | 309,000 |
| Cash flow from operations | 4,250,000 | -2,983,000 | -5,725,000 | 321,925,000 | 51,617,000 | 26,648,000 | -388,364,000 | 16,532,000 | 11,988,000 | 25,911,000 | -28,151,000 | -46,640,000 | 37,367,000 | -38,976,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | -80,402,000 | 0 | 0 | -266,210,000 | 16,801,000 | 18,851,000 | -1,001,231,000 | -197,692,000 | 0 | 0 | -114,766,000 | 1,625,405,000 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 9,798,000 | 1,286,000 | -32,847,000 | -247,148,000 | -11,693,000 | -1,187,000 | -582,734,000 | 6,454,000 | 796,829,000 | -2,171,000 | 25,660,000 | 5,672,000 | -30,907,000 | 74,077,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | -530,000 | 481,000 | 7,000 | 42,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -788,655,000 | -13,000 | 788,668,000 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 2,000 | 0 | -697,000 | 697,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -33,000 | 20,000 | -898,000 | -1,101,000 | -2,664,000 | -3,856,000 | -29,925,000 | -18,927,000 | -17,257,000 | -16,820,000 | -2,860,000 | -866,000 | -2,097,000 | -2,113,000 |
| cash flow from financing | -86,000,000 | 2,982,000 | -874,280,000 | -247,330,000 | -24,033,000 | 3,852,000 | -612,842,000 | -13,201,000 | -8,988,000 | -18,976,000 | -81,373,000 | 1,673,444,000 | -32,836,000 | 39,244,000 |
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | -15,000 | -288,000 | 141,000 | -27,000 | 168,000 | 21,000 | -95,000 | 95,000 | -300,000 | -76,000 | 283,000 | 93,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -916,000 | 916,000 | -235,000 | 235,000 | 0 | 0 | 0 |
| change in cash | 0 | 0 | -15,000 | -288,000 | 141,000 | -27,000 | 168,000 | 937,000 | -1,011,000 | 330,000 | -535,000 | -76,000 | 283,000 | 93,000 |
ge healthcare uk limited Credit Report and Business Information
Ge Healthcare Uk Limited Competitor Analysis
Perform a competitor analysis for ge healthcare uk limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
ge healthcare uk limited Ownership
GE HEALTHCARE UK LIMITED group structure
Ge Healthcare Uk Limited has 2 subsidiary companies.
Ultimate parent company
GENERAL ELECTRIC COMPANY
#0001064
2 parents
GE HEALTHCARE UK LIMITED
03337033
2 subsidiaries
ge healthcare uk limited directors
Ge Healthcare Uk Limited currently has 2 directors. The longest serving directors include Ms Katherine Jones (Nov 2019) and Sejal Dhillon (Apr 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Katherine Jones | United Kingdom | 47 years | Nov 2019 | - | Director |
| Sejal Dhillon | United Kingdom | 60 years | Apr 2020 | - | Director |
P&L
December 2022turnover
16.5m
+12%
operating profit
439k
-54%
gross margin
4%
-42.64%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
15.7m
-0.86%
total assets
28.5m
-0.75%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
ge healthcare uk limited company details
company number
03337033
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
March 1997
age
27
accounts
Full Accounts
ultimate parent company
previous names
amersham biosciences uk limited (January 2006)
amersham pharmacia biotech uk limited (January 2002)
See moreincorporated
UK
address
pollards wood nightingales lane, chalfont st. giles, buckinghamshire, HP8 4SP
last accounts submitted
December 2022
ge healthcare uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ge healthcare uk limited.
ge healthcare uk limited Companies House Filings - See Documents
| date | description | view/download |
|---|
